Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas
(Q46630773)
scientific article published on 23 April 2008
scientific article published on 23 April 2008
Language:
Current Data About
Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas
other details
| description | scientific article published on 23 April 2008 |
External Links
| (P356) |
10.1007/S11060-008-9600-Y
|
| (P698) |
18431544
|